Global prevalence of erectile dysfunction and its associated risk factors among men with type 1 diabetes: a systematic review and meta-analysis.
Zhang X, Zhu Z, Tang G.
Int J Impot Res. 2024 Jun;36(4):365-374. doi: 10.1038/s41443-024-00855-0. Epub 2024 Feb 23.
PMID:38396263
Erectile Dysfunction in Individuals with Type 1 Diabetes is Associated with Long-term Metabolic Control and Diabetic Complications: A Cross-Sectional Study.
Kamiński M, Kulecki M, Lachowski P, Kasprzak D, Kulczycka A, Kozłowska M, Klause D, Uruska A, Michalski M, Zozulińska-Ziółkiewicz D.
Int J Angiol. 2022 Jan 13;31(2):97-106. doi: 10.1055/s-0041-1735209. eCollection 2022 Jun.
Inhibition of inducible nitric oxide synthase improved erectile dysfunction in rats with type 1 diabetes.
Liu L, Wang X, Liu K, Kang J, Wang S, Song Y, Zhou K, Yi L, Liu X.
Andrologia. 2021 Sep;53(8):e14138. doi: 10.1111/and.14138. Epub 2021 Jun 16.
PMID:34137064
Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
Hippisley-Cox J, Coupland C, Brindle P.
BMJ. 2017 May 23;357:j2099. doi: 10.1136/bmj.j2099.
PMID:28536104
Evaluating the Impact of Continuous Glucose Monitoring on Erectile Dysfunction in Type 1 Diabetes: A Focus on Reducing Glucose Variability and Inflammation.
Tecce N, Menafra D, Proganò M, Tecce MF, Pivonello R, Colao A.